---
document_datetime: 2023-09-21 18:09:18
document_pages: 4
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/photobarr-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
document_name: photobarr-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 3.2036528
conversion_datetime: 2025-12-26 17:00:06.671836
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
<!-- image -->

## PhotoBarr

Procedural steps taken and scientific information after the authorisation

| No      | Scope                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3 Summary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| T/0027  | Transfer of Marketing Authorisation Holder                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 17/06/2011                          | 27/07/2011                                  | SPC, Labelling, PL SPC, PL longer                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| II/0023 | Following the review of the MAH safety database and a literature review, the MAH proposes an update of sections 4.4 of the Summary of Product Characteristics (SmPC) to include information regarding the risk of thrombo-embolic events and hypersensitivity. Recommendation regarding hypersensitivity has also been included in the SmPC. In addition, a revision of section 4.8 of the SmPC is proposed. The Package leaflet (PL) has been updated accordingly. Furthermore, the MAH took the opportunity of this variation to harmonise the SmPC with the Core Data Sheet (CDS) and to revise the product information in line with the latest version of the QRD template (version 7.3). C.I.4 - Variations related to significant modifications of the Summary of Product | 18/11/2010 product                  | 06/01/2011 no                               | Following the report of two cases of deep vein thrombosis in relation to PhotoBarr, the MAH conducted a review of all cases of thrombo-embolic events in the company safety database and a literature review. The risk of thrombo-embolic events has been assessed as probably related to PhotoBarr and the MAH has updated sections 4.4 and 4.8 of the SmPC. In addition, following the report of one case of anaphylaxis assessed to be related to photodynamic therapy with PhotoBarr, the MAH has updated sections 4.2, 4.4 and 4.8 to include the risk of hypersensitivity reactions. Furthermore, an analysis of the MAH's post marketing database was conducted by System Organ Class and based on causality assessment, section 4.8 of the SmPC has been updated. |

<!-- image -->

<!-- image -->

Medicinal product no longer authorised

2 No Commission Decision is issued for type IA and type IB variations or for type II variations and annual re-assessments that do not affect the annexes.

3 SPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

7 Westferry Circus ● Canary Wharf ● London E14 4HB ● United Kingdom

Telephone

+44 (0)20 7418 8400 Facsimile +44 (0) 20 7523 7455

E-mail

info@ema.europa.eu Website www.ema.europa.eu

<!-- image -->

<div style=\"page-break-after: always\"></div>

<!-- image -->

| No        | Scope                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|
|           | quality, pre-clinical, clinical or pharmacovigilance data                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |                                     |                                             |                                  |
| II/0026   | to introduce an alternative method for the routine testing of PhotoBarr and to add the corresponding new specification parameter in the finished product specification. B.II.d.1.z - Change in the specification parameters and/or limits of the finished product - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 23/09/2010                          | 01/10/2010                                  | authorised                       |
| IA/0025/G | This was an application for a group of variations. To change in the name of manufacturing site Draxis Pharma, a division of Draxis Specialty Pharmaceuticals to DRAXIS Specialty Pharmaceuticals Inc. To change in the adress of a manufacturing site involved in manufacture and testing of Photofrin from Bactimm BV Middenkampweg 17, 6545 CH Nijmegen NL, to Bactimm BV Middenkampweg 19, 6545 CH Nijmegen NL. A.5.b - Administrative change - Change in the name and/or address of a manufacturer of the finished product, including quality control sites (excluding manufacturer for batch release), A.4 - Administrative change - Change in the name and/or address of a manufacturer or supplier of the active substance, starting material, reagent or intermediate used in the manufacture of the active substance Medicinal | 04/06/2010 product                  | n/a no                                      | longer                           |
| IA/0024   | A.5.a - Administrative change - Change in the name and/or address of a manufacturer of the manufacturer responsible for batch release                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 25/05/2010                          | n/a                                         | Annex II, PL                     |

<div style=\"page-break-after: always\"></div>

| No      | Scope                                                                                                                                                                                                         | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| R/0020  | Renewal of the marketing authorisation                                                                                                                                                                        | 18/12/2008                          | 04/03/2009                                  | SPC, Annex II, Labelling, PL     | authorised                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| IA/0021 | 07_a_Replacement/add. of manufacturing site: Secondary packaging site, 08_b_01_Change in BR/QC testing - repl./add. manuf. responsible for BR - not incl. BC/testing                                          | 12/12/2008                          | n/a                                         | Annex II, PL                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| IA/0019 | 08_a_Change in BR/QC testing - repl./add. of batch control/testing site                                                                                                                                       | 06/09/2007                          | n/a                                         |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| II/0017 | Quality changes                                                                                                                                                                                               | 19/07/2007                          | 25/07/2007                                  | longer                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| IB/0018 | 14_b_Change in manuf. of active substance without Ph. Eur. certificate - new manufacturer                                                                                                                     | 06/07/2007                          | n/a                                         |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| IB/0016 | 17_b_Change in the storage conditions for the active substance                                                                                                                                                | 18/06/2007                          | n/a no                                      |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| IB/0015 | 30_b_Change in supplier of packaging components - replacement/addition                                                                                                                                        | 14/05/2007                          | n/a product                                 |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| IB/0013 | 07_c_Replacement/add. of manufacturing site: All other manufacturing operations ex. batch release, IA_08_b_01_Change in BR/QC testing - repl./add. manuf. responsible for BR - not incl. BC/testing Medicinal | 13/04/2007                          | n/a                                         | Annex II, PL                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| II/0012 | Update of Summary of Product Characteristics and Package Leaflet                                                                                                                                              | 21/09/2006                          | 23/10/2006                                  | SPC, PL                          | The MAH applied for a type II variation, upon request by the CHMP following the assessment of FUM 024 and FU2 024.1, to update sections 4.2 and 4.4 of the SPC to include further recommendations for patients with hepatic impairment. The PL has been updated accordingly. The influence of hepatic impairment on exposure to PhotoBarr has not been evaluated and no pharmacokinetic and safety data in patients with hepatic impairment are available. Based on evidence for a primarily hepatic/biliary elimination of photoactive substances, severity of phototoxic reactions and duration of the period of photosensitivity in patients with any grade of hepatic impairment may be increased. PhotoBarr is contraindicated in |

<div style=\"page-break-after: always\"></div>

<!-- image -->

| No      | Scope                                                                                            | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3      | Summary                                                                                                                                                                                                                                                                             |
|---------|--------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|-------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0010 | Quality changes                                                                                  | 21/09/2006                          | 25/09/2006                                  |                                     | authorised                                                                                                                                                                                                                                                                          |
| IA/0011 | 05_Change in the name and/or address of a manufacturer of the finished product                   | 28/04/2006                          | n/a                                         |                                     |                                                                                                                                                                                                                                                                                     |
| II/0008 | Update of Summary of Product Characteristics, Labelling and Package Leaflet                      | 17/11/2005                          | 23/12/2005                                  | SPC, Annex II, Labelling, PL longer | The MAH applied for an administrative type II variation to implement minor editorial changes in the Summary of Product Characteristics, Annex II, Labelling and Package Leaflet. In addition, the MAH took the opportunity to bring the annexes line with the latest QRD templates. |
| II/0007 | Update of or change(s) to the pharmaceutical documentation                                       | 13/10/2005                          | 18/10/2005 product no                       |                                     |                                                                                                                                                                                                                                                                                     |
| N/0003  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification) | 11/11/2004                          | n/a                                         | Labelling, PL                       |                                                                                                                                                                                                                                                                                     |
| IA/0004 | 08_a_Change in BR/QC testing - repl./add. of batch control/testing site                          | 29/10/2004                          | n/a                                         |                                     |                                                                                                                                                                                                                                                                                     |
| IA/0001 | 08_a_Change in BR/QC testing - repl./add. of batch control/testing site Medicinal                | 06/05/2004                          | n/a                                         |                                     |                                                                                                                                                                                                                                                                                     |